A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia.
Shah, Nisarg J; Najibi, Alexander J; Shih, Ting-Yu; Mao, Angelo S; Sharda, Azeem; Scadden, David T; Mooney, David J.
Nat Biomed Eng
; 4(1): 40-51, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31937942
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.
Lifting the Differentiation Embargo.
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis.
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
Effective Murine Model Induction for Niche Study in Immune Cells Against Leukemia.
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.
A new therapeutic target for leukemia comes to the surface.
How One Thing Led to Another.
Improved survival of AML patients by addition of cladribine to standard induction chemotherapy.